Doxorubicin Terminated Phase 2 Trials for Liver Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00524316Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery